UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (18), p.4921-4933

2017

Volltextzugriff (PDF)

TAZ expression as a prognostic indicator in colorectal cancer

PloS one, 2013-01, Vol.8 (1), p.e54211-e54211

2013

Volltextzugriff (PDF)

DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer

Cancers, 2018-08, Vol.10 (9), p.282

2018

Volltextzugriff (PDF)

A role of autophagy in PTP4A3-driven cancer progression

Autophagy, 2014-10, Vol.10 (10), p.1787-1800

2014

Volltextzugriff (PDF)

Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition

The Journal of pathology, 2011-05, Vol.224 (1), p.78-89

2011

Volltextzugriff (PDF)

DJ-1 Could Predict Worse Prognosis in Esophageal Squamous Cell Carcinoma

Cancer epidemiology, biomarkers & prevention, 2008-12, Vol.17 (12), p.3593-3602

2008

Volltextzugriff (PDF)

Erythropoietin drives breast cancer progression by activation of its receptor EPOR

Oncotarget, 2017-06, Vol.8 (24), p.38251-38263

2017

Volltextzugriff (PDF)

Identification of TWIST-interacting genes in prostate cancer

Science China. Life sciences, 2017-04, Vol.60 (4), p.386-396

2017

Volltextzugriff (PDF)

Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression

Cancer science, 2012-06, Vol.103 (6), p.1145-1154

2012

Volltextzugriff (PDF)

Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform

Clinical cancer research, 2009-07, Vol.15 (13), p.4322-4335

2009

Volltextzugriff (PDF)

Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself

PloS one, 2015-02, Vol.10 (2), p.e0118187-e0118187

2015

Volltextzugriff (PDF)

Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis

Journal of clinical pathology, 2007-05, Vol.60 (5), p.510-514

2007

Volltextzugriff (PDF)

The prognostic significance of Cdc6 and Cdt1 in breast cancer

Scientific reports, 2017-04, Vol.7 (1), p.985-11, Article 985

2017

Volltextzugriff (PDF)

TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction

Carcinogenesis (New York), 2008-08, Vol.29 (8), p.1509-1518

2008

Volltextzugriff (PDF)

In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer

Journal of cellular and molecular medicine, 2018-09, Vol.22 (9), p.4097-4105

2018

Volltextzugriff (PDF)

Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer‐related cells

Cancer science, 2010-06, Vol.101 (6), p.1354-1360

2010

Volltextzugriff (PDF)

The Role of Pea3 Group Transcription Factors in Esophageal Squamous Cell Carcinoma

The American journal of pathology, 2011-08, Vol.179 (2), p.992-1003

2011

Volltextzugriff (PDF)

Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells

Bioscience reports, 2012-08, Vol.32 (4), p.413-422

2012

Volltextzugriff (PDF)

The prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer

OncoTargets and therapy, 2015-01, Vol.8, p.1707-1717

2015

Volltextzugriff (PDF)

Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells

The Journal of clinical investigation, 2013-08, Vol.123 (8), p.3459-3471

2013

Volltextzugriff (PDF)

Interleukin-2 induces NF-κB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells

The Journal of pathology, 2010-06, Vol.221 (2), p.164-174

2010

Volltextzugriff (PDF)

Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases

Modern pathology, 2006-07, Vol.19 (7), p.931-941

2006

Volltextzugriff (PDF)

Correction: TAZ Expression as a Prognostic Indicator in Colorectal Cancer

PloS one, 2021-04, Vol.16 (4), p.e0250187-e0250187

2021

Volltextzugriff (PDF)

Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways

Clinical cancer research, 2012-01, Vol.18 (2), p.380-391

2012

Volltextzugriff (PDF)

Ran GTPase promotes cancer progression via Met receptor-mediated downstream signaling

Oncotarget, 2016-11, Vol.7 (46), p.75854-75864

2016

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(54)
Dissertationen
(2)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway

TAZ expression as a prognostic indicator in colorectal cancer

DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer

A role of autophagy in PTP4A3-driven cancer progression

Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition

DJ-1 Could Predict Worse Prognosis in Esophageal Squamous Cell Carcinoma

Erythropoietin drives breast cancer progression by activation of its receptor EPOR

Identification of TWIST-interacting genes in prostate cancer

Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression

Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform

Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself

Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis

The prognostic significance of Cdc6 and Cdt1 in breast cancer

TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction

In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer

Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer‐related cells

The Role of Pea3 Group Transcription Factors in Esophageal Squamous Cell Carcinoma

Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells

The prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer

Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells

Interleukin-2 induces NF-κB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells

Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases

Correction: TAZ Expression as a Prognostic Indicator in Colorectal Cancer

Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways

Ran GTPase promotes cancer progression via Met receptor-mediated downstream signaling

Suchergebnisse filtern